Back to top

Top Ranked Momentum Stocks to Buy for September 12th

Read MoreHide Full Article

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, September 12th:

Alexco Resource Corp. (AXU - Free Report) : This environmental consulting services company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 33.3% over the last 60 days.

Alexco Resource’s shares gained 29% over the last one month more than S&P 500’s rise of 4.1%. The company possesses a Momentum Score of A.

Option Care Health, Inc. (BIOS - Free Report) : This independent home and alternate site infusion services provider has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 21.7% over the last 60 days.

Option Care Health’s shares gained 8.2% over the last one month. The company possesses a Momentum Score of A.

Tech Data Corporation (TECD - Free Report) : This IT distribution and solutions company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4% over the last 60 days.

Tech Data’s shares gained 21.2% over the last one month. The company possesses a Momentum Score of B.

Photronics, Inc. (PLAB - Free Report) : This semiconductor photomask manufacturer has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.1% over the last 60 days.

Photronics’ shares gained 25% over the last one month. The company possesses a Momentum Score of B.

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>